Potential of brain age in identifying early cognitive impairment in subcortical small-vessel disease patients
Authors:
Open Access
- 1 September 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 14, 973054
Abstract
Background: Reliable and individualized biomarkers are crucial for identifying early cognitive impairment in subcortical small-vessel disease (SSVD) patients. Personalized brain age prediction can effectively reflect cognitive impairment. Thus, the present study aimed to investigate the association of brain age with cognitive function in SSVD patients and assess the potential value of brain age in clinical assessment of SSVD.Materials and methods: A prediction model for brain age using the relevance vector regression algorithm was developed using 35 healthy controls. Subsequently, the prediction model was tested using 51 SSVD patients [24 subjective cognitive impairment (SCI) patients and 27 mild cognitive impairment (MCI) patients] to identify brain age-related imaging features. A support vector machine (SVM)-based classification model was constructed to differentiate MCI from SCI patients. The neurobiological basis of brain age-related imaging features was also investigated based on cognitive assessments and oxidative stress biomarkers.Results: The gray matter volume (GMV) imaging features accurately predicted brain age in individual patients with SSVD (R2 = 0.535, p < 0.001). The GMV features were primarily distributed across the subcortical system (e.g., thalamus) and dorsal attention network. SSVD patients with age acceleration showed significantly poorer Mini-Mental State Examination and Montreal Cognitive Assessment (MoCA) scores. The classification model based on GMV features could accurately distinguish MCI patients from SCI patients (area under the curve = 0.883). The classification outputs of the classification model exhibited significant associations with MoCA scores, Trail Making Tests A and B scores, Stroop Color and Word Test C scores, information processing speed total scores, and plasma levels of total antioxidant capacity in SSVD patients.Conclusion: Brain age can be accurately quantified using GMV imaging data and shows potential clinical value for identifying early cognitive impairment in SSVD patients.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 42 references indexed in Scilit:
- Resting state fMRI regional homogeneity correlates with cognition measures in subcortical vascular cognitive impairmentJournal of the Neurological Sciences, 2017
- The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional ArchitectureCerebral Cortex, 2016
- Prediction of Impaired Performance in Trail Making Test in MCI Patients With Small Vessel Disease Using DTI DataIEEE Journal of Biomedical and Health Informatics, 2016
- Opposite Neural Trajectories of Apolipoprotein E ϵ4 and ϵ2 Alleles with Aging Associated with Different Risks of Alzheimer's DiseaseCerebral Cortex, 2014
- Abnormalities of cortical thickness, subcortical shapes, and white matter integrity in subcortical vascular cognitive impairmentHuman Brain Mapping, 2013
- BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s DiseasePLOS ONE, 2013
- Vascular Contributions to Cognitive Impairment and DementiaStroke, 2011
- The organization of the human cerebral cortex estimated by intrinsic functional connectivityJournal of Neurophysiology, 2011
- Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challengesThe Lancet Neurology, 2010
- A comparison of methods for multiclass support vector machinesIEEE Transactions on Neural Networks, 2002